SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-051981
Filing Date
2022-10-03
Accepted
2022-10-03 19:51:09
Documents
1
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3958
  Complete submission text file 0001209191-22-051981.txt   5358
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Kupchyk Areta (Reporting) CIK: 0001859718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 221289263